estrategia de busqueda

Andrea Garcia
Cleofe enith Medina

estrategia de busqueda
Tema: Leucemia Mieloide cronica

leukemia/myeloid,chronic/drug therapy(Mesh) Or
"leukemia, myeloid chronic/ therapy (Mesh)
resistance treatment

1: Timeus F, Crescenzio N, Ricotti E, Doria A, Bertin D, Saglio G, Tovo PA.
The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia
cell lines.
Haematologica. 2006 May;91(5):711-2.
PMID: 16670078 [PubMed - indexed for MEDLINE]

2: Wang L, Knight K, Lucas C, Clark RE.
The role of serial BCR-ABL transcript monitoring in predicting the emergence
of
BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid
leukemia.
Haematologica. 2006 Feb;91(2):235-9.
PMID: 16461309 [PubMed - indexed for MEDLINE]

3: Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong
A,
Pattacini L, Goldman JM, Melo JV.
Bcr-Abl expression levels determine the rate of development of resistance to
imatinib mesylate in chronic myeloid leukemia.
Cancer Res. 2005 Oct 1;65(19):8912-9.
PMID: 16204063 [PubMed - indexed for MEDLINE]

4: O'Hare T, Walters DK, Stoffregen EP, Sherbenou DW, Heinrich MC,
Deininger
MW, Druker BJ.
Combined Abl inhibitor therapy for minimizing drug resistance in chronic
myeloid leukemia: Src/Abl inhibitors are compatible with imatinib.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6987-93.
PMID: 16203792 [PubMed - indexed for MEDLINE]

5: Komarova NL, Wodarz D.
Drug resistance in cancer: principles of emergence and prevention.
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9714-9. Epub 2005 Jun 24.
PMID: 15980154 [PubMed - indexed for MEDLINE]

_________________________________________________________________
Charla con tus amigos en línea mediante MSN Messenger:

http://messenger.latam.msn.com/